Results 91 to 100 of about 4,852 (116)

[Physical Activity and Exercise Prescription Plans in Primary Care in Spain: A Comparative Analysis by Autonomous Community]. [PDF]

Aten Primaria
Gutiérrez Moraño P, Palomo López P, Aredo Tisnado AC, Ramírez Durán MDV.   +3 more
europepmc   +1 more source

[Association of cigarette consumption, nicotine derivatives and cannabis with periodontal disease. A review]. [PDF]

Rev Cient Odontol (Lima)
Valenzuela-Torres OY, Zapata-Sifuentes MA, Quispe-Salcedo A.   +2 more
europepmc   +1 more source

Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis. [PDF]

Front Public Health
Monreal E, Ruiz PD, San Román IL, Rodríguez-Antigüedad A, Moya-Molina MÁ, Álvarez A, García-Arcelay E, Maurino J, Shepherd J, Cabrera ÁP, Villar LM.   +10 more
europepmc   +1 more source

Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes <i>GLB1</i>, <i>SLC6A3</i>, <i>SLC30A10</i>, <i>SLC39A14</i>, and <i>PLA2G6</i>: MDSGene Systematic Review. [PDF]

Int J Mol Sci
Rodriguez-Antiguedad J, Rajalingam R, Krüger C, Teixeira-Dos-Santos D, Sun C, Fernandez-Toledo E, Duarte A, Saffie-Awad P, Barrett MJ, Flanigan JL, Emamikhah M, Patel N, San Luciano M, Cooper C, Bahr N, Oguh O, Buhrmann A, Vater M, Fuchshofen R, Vulinovic F, Parreidt MI, Weissbach A, Lohmann K, Klein C, Marras C, Camargos S.   +25 more
europepmc   +1 more source

Cognitive function is associated with the progression of non-tremor motor symptoms in Parkinson's disease. [PDF]

Front Aging Neurosci
Gibbs MC, D'Souza A, Sotirakis C, Crawford TJ, Antoniades CA.   +4 more
europepmc   +1 more source

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management. [PDF]

Ther Adv Neurol Disord
Oreja-Guevara C, Martínez-Yélamos S, Eichau S, Llaneza MÁ, Martín-Martínez J, Peña-Martínez J, Meca-Lallana V, Alonso-Torres AM, Moral-Torres E, Río J, Calles C, Ares-Luque A, Ramió-Torrentà L, Marzo-Sola ME, Prieto JM, Martínez-Ginés ML, Arroyo R, Otano-Martínez MÁ, Brieva-Ruiz L, Gómez-Gutiérrez M, Rodríguez-Antigüedad A, Galán Sánchez-Seco V, Costa-Frossard L, Hernández-Pérez MÁ, Landete-Pascual L, González-Platas M, Meca-Lallana JE.   +26 more
europepmc   +1 more source

Economic burden of secondary progressive multiple sclerosis: DISCOVER study. [PDF]

BMC Health Serv Res
Oreja-Guevara C, Meca-Lallana JE, Gómez-Estévez I, Ara JR, Pérez MÁH, Gil JG, Torres AMA, de la Fuente BP, Ramió-Torrentà L, Madueño SE, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Valcárcel MA, Ginés MLM, Montero YEB, Real AML, González-Quintanilla V, de Silanes CL, Martínez-Rodríguez JE, Costa-Frossard L, Redondo MG, Fontcuberta AL, Castellanos-Pinedo F, Merino JAG, Fernández CM, Castillo-Triviño T, Meca-Lallana V, Martínez JP, Rodríguez-Antigüedad A, González JMP, Morales EA, Molina IP, Sánchez DMS, Varo NH, Vázquez MA, Barrios JMR, Río J.   +37 more
europepmc   +1 more source

Body Fluid-based Biomarkers for Cognitive Impairment in Parkinson's Disease. [PDF]

Ann Neurosci
R R, Choudhury S, N C K, Bharath MMS, Rathod BLS, Yadav R, Alladi PA.   +6 more
europepmc   +1 more source